Safety and efficacy of off-label use of biologic therapies in patients with inflammatory rheumatic diseases refractory to standard of care therapy : Data from a nationwide German registry (GRAID2)

Proft, F ; Schulze-Koops, H ; Grunke, M ; Schrezenmeier, E ; Halleck, F ; Henes, J ; Unger, L ; Schmidt, E ; Fiehn, C ; Jacobi, A ; Iking-Konert, C ; Kneitz, C ; Schmidt, R E ; Bannert, B ; Voll, R E ; Fischer-Betz, R ; Kötter, I ; Tony, H P ; Holle, J ; Aringer, M ; Erler, A ; Behrens, F ; Burmester, G R ; Dörner, T

Zeitschrift für Rheumatologie, 2018-02, Vol.77 (1), p.28-39 [Periódico revisado por pares]

Germany

Texto completo disponível